No Data
No Data
Trade Alert: Chief Business Officer & Secretary Of ARS Pharmaceuticals Justin Chakma Has Sold Stock
Form 144 | ARS Pharmaceuticals(SPRY.US) Officer Proposes to Sell 4.09 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 15, $ARS Pharmaceuticals(SPRY.US)$ Officer Chakma Justin intends to sell 236.38K shares of its common stock on Nov 15, with a total market value of approximately $4.09
Express News | Neurelis Enters $208 Million Agreement to Monetize Intravail Royalties
ARS Pharmaceuticals Insider Sold Shares Worth $10,143,706, According to a Recent SEC Filing
Express News | ARS Pharmaceuticals Inc : Leerink Partners Raises Target Price to $26 From $25
ARS Pharmaceuticals' Strong Q3 2024 Highlights
No Data
No Data